Kaiser Faces Uphill Battle To Nix Generic Drug Cost Suit

Law360, Los Angeles (August 10, 2017, 8:57 PM EDT) -- A California judge Thursday tentatively rejected Kaiser Foundation Health Plan’s bid to toss a putative class action claiming it inflates certain generic drug prices, but said he’d rethink the matter after Kaiser argued that its promise for some below-copayment prices shouldn’t open the company to allegations its prices could be lower.

Prior to Thursday’s hearing, Los Angeles Superior Court Judge Kenneth Freeman issued a tentative written ruling denying Kaiser’s motion to dismiss plaintiff Wendy Gallimore’s amended complaint, but following oral arguments said he was not quite...
To view the full article, register now.